Cargando…
A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues
PURPOSE: Most chemotherapeutic agents possess poor water solubility and show more significant accumulations in normal tissues than in tumor tissues, resulting in serious side effects. To this end, a novel dextran-based dual drug delivery system with high biodistribution ratio of tumors to normal tis...
Autores principales: | Liu, Jiaojiao, Zhang, Naining, Wu, Jiaan, Dong, Peng, Lv, Hongshuai, Wang, Qi, Wang, Shenxu, Yang, Haotong, Wang, Si, Li, Xiaohai, Hu, Jinghua, Wang, Anny, Li, Daisy J, Shi, Yikang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576339/ https://www.ncbi.nlm.nih.gov/pubmed/36262192 http://dx.doi.org/10.2147/IJN.S379758 |
Ejemplares similares
-
Polysaccharide dextran-based conjugate for selective co-delivery of two synergistic drugs docetaxel and docosahexaenoic acid to tumor cells
por: Dong, Peng, et al.
Publicado: (2022) -
Penetration of Nanobody-Dextran Polymer Conjugates through Tumor Spheroids
por: Bitsch, Peter, et al.
Publicado: (2023) -
A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles
por: Zu, Yuangang, et al.
Publicado: (2011) -
Maleimidation of dextran and the application in designing a dextran–camptothecin conjugate
por: Zhu, Qiwen, et al.
Publicado: (2018) -
Biodistribution of essential oil-conjugated silver nanoparticles
por: Gherasim, Oana, et al.
Publicado: (2020)